Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
Nov 02, 2022•18 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.
For the best experience, listen in Metacast app for iOS or Android